AXSM
NASDAQ
$236.95
Axsome Therapeutics Inc (AXSM)
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $280.39 (+18.33%)
Market Cap
$12B
Free Cash Flow Yield
-0.58%
Beta (5Y)
0.66
Price Chart
Valuation
Market Cap$12B
Forward P/E333.33
P/S17.09
P/B221.78
Profitability
Total Revenue (TTM)$708M
Gross Profit (TTM)$656M
EBITDA-$173M
Profit Margin-33.8%
Operating Margin-33.1%
EPS-$3.72
Financial Health
Debt-to-Equity344.1%
Free Cash Flow Yield-0.58%
Growth & Risk
EPS 5Y CAGR+6.89%
FCF 5Y CAGR-2.95%
Beta (5Y)0.66
Sharpe Ratio1.72